Various pathways leading to the progression of chronic liver diseases
As the result of various effects (viruses, metabolic diseases, nutritional factors, toxic agents, autoimmune processes) abnormal liver function, liver steatosis and connective tissue remodeling may develop. Progression of this process is complex including various pathways and a number of factors. The authors summarize the factors involved in the progression of chronic liver disease. They describe the role of cells and the produced inflammatory mediators and cytokines, as well as the relationship between the disease and the intestinal flora. They emphasize the role of oxidative stress, mitochondrial dysfunction and cell death in disease progression. Insulin resistance and micro-elements (iron, copper) in relation to liver damage are also discussed, and genetic and epigenetic aspects underlying disease progression are summarized. Discovery of novel treatment options, assessment of the effectiveness of treatment, as well as the success and proper timing of liver transplantation may depend on a better understanding of the process of disease progression.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:157 |
---|---|
Enthalten in: |
Orvosi hetilap - 157(2016), 8 vom: 21. Feb., Seite 290-7 |
Sprache: |
Ungarisch |
---|
Weiterer Titel: |
Az idült májbetegségek progressziójához vezető folyamatok |
---|
Beteiligte Personen: |
Egresi, Anna [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 25.04.2016 Date Revised 15.02.2016 published: Print Citation Status MEDLINE |
---|
doi: |
10.1556/650.2015.30377 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM257470077 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM257470077 | ||
003 | DE-627 | ||
005 | 20231224182911.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||hun c | ||
024 | 7 | |a 10.1556/650.2015.30377 |2 doi | |
028 | 5 | 2 | |a pubmed24n0858.xml |
035 | |a (DE-627)NLM257470077 | ||
035 | |a (NLM)26876265 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a hun | ||
100 | 1 | |a Egresi, Anna |e verfasserin |4 aut | |
245 | 1 | 0 | |a Various pathways leading to the progression of chronic liver diseases |
246 | 3 | 3 | |a Az idült májbetegségek progressziójához vezető folyamatok |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.04.2016 | ||
500 | |a Date Revised 15.02.2016 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a As the result of various effects (viruses, metabolic diseases, nutritional factors, toxic agents, autoimmune processes) abnormal liver function, liver steatosis and connective tissue remodeling may develop. Progression of this process is complex including various pathways and a number of factors. The authors summarize the factors involved in the progression of chronic liver disease. They describe the role of cells and the produced inflammatory mediators and cytokines, as well as the relationship between the disease and the intestinal flora. They emphasize the role of oxidative stress, mitochondrial dysfunction and cell death in disease progression. Insulin resistance and micro-elements (iron, copper) in relation to liver damage are also discussed, and genetic and epigenetic aspects underlying disease progression are summarized. Discovery of novel treatment options, assessment of the effectiveness of treatment, as well as the success and proper timing of liver transplantation may depend on a better understanding of the process of disease progression | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a csillagsejtek | |
650 | 4 | |a fibrosis | |
650 | 4 | |a hepatitis | |
650 | 4 | |a intestinal flora | |
650 | 4 | |a intestinalis bélflóra | |
650 | 4 | |a liver steatosis | |
650 | 4 | |a mitochondrial dysfunction | |
650 | 4 | |a mitokondriális diszfunkció | |
650 | 4 | |a májelzsírosodás | |
650 | 4 | |a oxidative stress | |
650 | 4 | |a oxidatív stressz | |
650 | 4 | |a progression | |
650 | 4 | |a progresszió | |
650 | 4 | |a stellate cells | |
650 | 7 | |a Adipokines |2 NLM | |
650 | 7 | |a Chemokines |2 NLM | |
650 | 7 | |a Cytokines |2 NLM | |
650 | 7 | |a Trace Elements |2 NLM | |
700 | 1 | |a Lengyel, Gabriella |e verfasserin |4 aut | |
700 | 1 | |a Somogyi, Anikó |e verfasserin |4 aut | |
700 | 1 | |a Blázovics, Anna |e verfasserin |4 aut | |
700 | 1 | |a Hagymási, Krisztina |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Orvosi hetilap |d 1949 |g 157(2016), 8 vom: 21. Feb., Seite 290-7 |w (DE-627)NLM000021601 |x 1788-6120 |7 nnns |
773 | 1 | 8 | |g volume:157 |g year:2016 |g number:8 |g day:21 |g month:02 |g pages:290-7 |
856 | 4 | 0 | |u http://dx.doi.org/10.1556/650.2015.30377 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 157 |j 2016 |e 8 |b 21 |c 02 |h 290-7 |